Molecular characterization of EZH2 mutant patients with myelodysplastic/myeloproliferative neoplasmsJenny Rinke(Jena University Hospital), Thomas Ernst(Jena University Hospital)LeukemiaJune 19, 201710.1038/leu.2017.190Cited by 32SaveCiteExport RISWatch citationsRelated PapersABL single nucleotide polymorphisms may masquerade as BCR-ABL mutations associated with resistance to tyrosine kinase inhibitors in patients with chronic myeloid leukemia|Haematologica|2008|50SIRT7: an influence factor in healthy aging and the development of age-dependent myeloid stem-cell disorders|Leukemia|2020|49